Effectiveness of Ecoguided Percutaneous Neuromodulation of the Multipurpose Musculature of L-3 in Non-specific Chronic Lumbar Pain.
CompletedNot applicableNCT03738748
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study evaluates the effectiveness of Ultrasound-guided Percutaneous Neuromodulation in the lumbar multifidus of L3 in non-specific chronic low back pain.
Study details
- Official title
- Effectiveness of the Ecoguided Percutaneous Neuromodulation of the Multipurpose Musculature of L-3 in Non-specific Chronic Lumbar Pain.
- Conditions
- Interventions
- Other: Ultrasound- guided Percutaneous Neuromulation
- Other: TENS Therapy
- Sponsor
- Universidad de Almeria
- Start date
- 2024-09-20
- Primary completion
- 2025-01-31
- Sex
- All
- Age range
- from 18 Years to 65 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Score ≥4 on the Roland Morris Disability Questionnaire. * Low back pain for ≥3 months * Age between 18 and 65 years * Not undergoing another physical therapy treatment Exclusion Criteria: * Presence of lumbar stenosis * Diagnosis of spondylolisthesis * Diagnosis of fibromyalgia * Treatment with corticosteroid or oral medication within the past two weeks * A history of spinal surgery * Contraindication of analgesic electrical therapy * Having previously received a treatment of electrical analgesia.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03738748